Touloumi G, Pantazis N, Stirnadel HA, Walker SA, Boufassa F, Vanhems P, Porter K, Collaboration C, others. Rates and determinants of virologic and immunological response to HAART resumption after treatment interruption in HIV-1 clinical practice. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2008;49:492–498.

Guiguet M, Porter K, Phillips A, Costagliola D, Babiker A. Clinical progression rates by CD4 cell category before and after the initiation of combination antiretroviral therapy (cART). The open AIDS journal. 2008;2:3.

Pantazis N, Touloumi G, Vanhems P, Gill J, Bucher HC, Porter K, Collaboration C, others. The effect of antiretroviral treatment of different durations in primary HIV infection. Aids. 2008;22:2441–2450.

Georgopoulou MK, Spanaki-Voreadi AP, Pantazis N, Kontakiotis EG, Morfis AS. Periapical status and quality of root canal fillings and coronal restorations in a Greek population. Quintessence international. 2008;39.

Jarrin I, Geskus R, Bhaskaran K, Prins M, Perez-Hoyos S, Muga R, Hernandez-Aguado I, Meyer L, Porter K, Del Amo J. Gender differences in HIV progression to AIDS and death in industrialized countries: slower disease progression following HIV seroconversion in women. American journal of epidemiology. 2008;168:532–540.

Bhaskaran K, Hamouda O, Sannes M, Boufassa F, Johnson AM, Lambert PC, Porter K, Collaboration C, others. Changes in the risk of death after HIV seroconversion compared with mortality in the general population. Jama. 2008;300:51–59.

Dunn D, Woodburn P, Duong T, Peto J, Phillips A, Gibb D, Porter K, (HPPMCS) HIVPPMCS, on to AIDS CAS-C, in Collaboration DE (CASCADE). Current CD4 cell count and the short-term risk of AIDS and death before the availability of effective antiretroviral therapy in HIV-infected children and adults. The Journal of infectious diseases. 2008;197:398–404.

of Group COHIVERE (COHERE) S, others. Response to combination antiretroviral therapy: variation by age. Aids. 2008;22:1463–1473.